Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Immune system drug may increase availability of liver transplants

30.07.2003


Animal research at The Johns Hopkins University School of Medicine has found that a drug already approved by the FDA for testing in people might one day dramatically expand the number of livers useable for human transplantation.



Studying rats with fatty livers, the researchers discovered that bathing the livers in a human immune system protein called interleukin-6 (IL-6) rescues them from failure when transplanted into other rats. The findings appear in the July issue of Gastroenterology.

Roughly 40 percent of adults in the United States have so-called "fatty" livers, which frequently fail to function at all or fail quickly when transplanted.


"IL-6 really works," says Zhaoli Sun, M.D., Ph.D., a scientist in the department of surgery. Sun cautions that IL-6’s ability to "rescue" fatty livers for transplantation needs to be tested in larger animals, such as pigs, before human studies are undertaken.

"IL-6 is already approved for use in humans, but it has many negative effects when injected," says Sun. "Fortunately, our technique stores the liver in IL-6 before it’s transplanted, rather than giving IL-6 to the organ recipient, so side effects should be minimized."

For his experiments, Sun developed two special rat colonies while an instructor in the laboratory of Andrew Klein, M.D., in collaboration with Anna Mae Diehl, M.D., a professor of gastroenterology whose research has focused on regeneration -- rather than transplantation -- of fatty liver. In humans, fatty livers generally stem from either diet or alcohol consumption, and the two rat models developed fatty livers under equivalent conditions.

After removing a fatty liver from one animal, and before transplanting it into another, Sun bathed the liver in a soup of nutrients that either did or did not include IL-6. Livers soaked in IL-6 had better blood flow and better function and allowed recipients to live, while fatty livers never exposed to IL-6 succumbed quickly to damage and never worked well enough to save their new hosts.

Sun says it’s not known yet how IL-6 protects the fatty livers from damage or how it improves so-called "microcirculation," which helps prevent large chunks of the liver from dying. But while those questions are interesting scientifically, Klein, director of the Johns Hopkins Comprehensive Transplant Center, says clinical trials won’t need to wait for those answers.

"Eventual clinical trials, if approved, would probably begin by looking for reduced damage or improved function in organs we would already use for transplant," says Klein, who notes that that a generally acceptable cutoff is a liver with no more than 30 percent of cells containing big droplets of fat. "Moving toward livers that currently would be borderline would be a gradual process."

Roughly 17,500 people are awaiting liver transplants in the United States, and 5,327 liver transplantations were performed last year across the country, according to statistics kept by the United Network for Organ Sharing. IL-6 has been administered to people as part of early phase clinical trials in adults and children with various cancers, but was limited by its toxicity.

Joanna Downer | EurekAlert!
Further information:
http://www.gastroenterology.com
http://www.hopkinsmedicine.org/transplant/adult/liver/index.html
http://www.unos.org

More articles from Health and Medicine:

nachricht Hot cars can hit deadly temperatures in as little as one hour
24.05.2018 | Arizona State University

nachricht 3D images of cancer cells in the body: Medical physicists from Halle present new method
16.05.2018 | Martin-Luther-Universität Halle-Wittenberg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Powerful IT security for the car of the future – research alliance develops new approaches

The more electronics steer, accelerate and brake cars, the more important it is to protect them against cyber-attacks. That is why 15 partners from industry and academia will work together over the next three years on new approaches to IT security in self-driving cars. The joint project goes by the name Security For Connected, Autonomous Cars (SecForCARs) and has funding of €7.2 million from the German Federal Ministry of Education and Research. Infineon is leading the project.

Vehicles already offer diverse communication interfaces and more and more automated functions, such as distance and lane-keeping assist systems. At the same...

Im Focus: Molecular switch will facilitate the development of pioneering electro-optical devices

A research team led by physicists at the Technical University of Munich (TUM) has developed molecular nanoswitches that can be toggled between two structurally different states using an applied voltage. They can serve as the basis for a pioneering class of devices that could replace silicon-based components with organic molecules.

The development of new electronic technologies drives the incessant reduction of functional component sizes. In the context of an international collaborative...

Im Focus: LZH showcases laser material processing of tomorrow at the LASYS 2018

At the LASYS 2018, from June 5th to 7th, the Laser Zentrum Hannover e.V. (LZH) will be showcasing processes for the laser material processing of tomorrow in hall 4 at stand 4E75. With blown bomb shells the LZH will present first results of a research project on civil security.

At this year's LASYS, the LZH will exhibit light-based processes such as cutting, welding, ablation and structuring as well as additive manufacturing for...

Im Focus: Self-illuminating pixels for a new display generation

There are videos on the internet that can make one marvel at technology. For example, a smartphone is casually bent around the arm or a thin-film display is rolled in all directions and with almost every diameter. From the user's point of view, this looks fantastic. From a professional point of view, however, the question arises: Is that already possible?

At Display Week 2018, scientists from the Fraunhofer Institute for Applied Polymer Research IAP will be demonstrating today’s technological possibilities and...

Im Focus: Explanation for puzzling quantum oscillations has been found

So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics

Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

In focus: Climate adapted plants

25.05.2018 | Event News

Save the date: Forum European Neuroscience – 07-11 July 2018 in Berlin, Germany

02.05.2018 | Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

 
Latest News

In focus: Climate adapted plants

25.05.2018 | Event News

Flow probes from the 3D printer

25.05.2018 | Machine Engineering

Less is more? Gene switch for healthy aging found

25.05.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>